Department of Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, Complutense University of Madrid, c/Arcos de Jalón 118, 28037, Madrid, Spain.
Department of Biochemistry and Molecular Biology IV, Faculty of Veterinary, Complutense University of Madrid, Av/ Puerta del Hierro s/n, 28040, Madrid, Spain.
Purinergic Signal. 2018 Sep;14(3):259-270. doi: 10.1007/s11302-018-9612-9. Epub 2018 Jun 8.
The pathogenesis of glaucoma involves numerous intracellular mechanisms including the purinergic system contribution. Furthermore, the presence and release of nucleotides and dinucleotides during the glaucomatous damage and the maintenance of degradation machinery through ecto-nucleotidase activity are participating in the modulation of the suitable extracellular complex balance. The aim of this study was to investigate the levels of diadenosine tetraphosphate (ApA) and the pattern of ecto-nucleotidase activity expression in glaucomatous retinas during the progress the pathology. ApA levels were analyzed by HPLC in glaucomatous retinas from the DBA/2J mice at 3, 9, 15, and 23 months of age. For that, retinas were dissected as flattened whole-mounts and stimulated in Ringer buffer with or without 59 mM KCl. NPP1 expression was analyzed by RT-PCR and western blot and its distribution was assessed by immunohistochemistry studies examined under confocal microscopy. Glaucomatous mice exhibited ApA values, which changed in stimulated retinas as long as the pathology progressed varying from 0.73 ± 0.04 (3 months) to 0.170 ± 0.05 pmol/mg retina (23 months). Concomitantly, NPP1 expression was significantly increased (82.15%) in the DBA/2J mice at 15 months. Furthermore, immunohistochemical studies showed that NPP1 labeling was stronger in OPL and IPL labeling tangentially in the vitreal part of the retina and was upregulated at 15 months of age. Our findings demonstrate that ApA decreased levels may be related with exacerbated activity of NPP1 protein in glaucomatous degeneration and in this way contributing to elucidate different mechanisms involved in retinal impairment in glaucomatous degeneration.
青光眼的发病机制涉及许多细胞内机制,包括嘌呤能系统的贡献。此外,在青光眼损伤过程中核苷酸和二核苷酸的存在和释放,以及通过外核苷酸酶活性维持降解机制,都参与了适当的细胞外复合物平衡的调节。本研究旨在探讨二腺苷四磷酸(ApA)的水平和外核苷酸酶活性表达模式在青光眼视网膜病变进展过程中的变化。通过高效液相色谱法分析了 DBA/2J 小鼠青光眼视网膜中的 ApA 水平,这些小鼠分别在 3、9、15 和 23 个月大时进行研究。为此,将视网膜作为扁平化的全层进行解剖,并在 Ringer 缓冲液中或含有 59mM KCl 的缓冲液中进行刺激。通过 RT-PCR 和 Western blot 分析 NPP1 的表达,并通过免疫组织化学研究在共聚焦显微镜下评估其分布。青光眼小鼠表现出 ApA 值,随着病理的进展,刺激视网膜中的 ApA 值发生变化,从 0.73±0.04(3 个月)变化到 0.170±0.05 pmol/mg 视网膜(23 个月)。同时,NPP1 在 15 个月的 DBA/2J 小鼠中表达显著增加(82.15%)。此外,免疫组织化学研究显示,NPP1 标记在 OPL 和 IPL 中更强,在视网膜玻璃体部分呈切线状,在 15 个月时上调。我们的研究结果表明,ApA 水平降低可能与青光眼变性中 NPP1 蛋白活性的加剧有关,并以此阐明青光眼变性中视网膜损伤涉及的不同机制。